Ownership

We are an independent company, majority owned by our employees.

Since 2007, Ceva’s management has been supported by carefully chosen, long-term financial partners who share our values and vision.

In April 2025, all our historical investors have renewed their confidence in our company, with some even raising their participation, which is a strong signal confirming the solidity of our strategy. Ceva’s management, led by Dr. Marc Prikazsky, has reinforced its participation reaffirming the company’s commitment to remaining independent.

We’ve also opened our capital to Institut Mérieux (already Ceva’s shareholder via Merieux Equity Partners) and Archimed, a French investment fund led by a veterinarian, Dr Denis Ribon, who will help us go even further in our ambition to develop innovative solutions for all animals and accelerate our growth.

To support innovation in animal health, the Bettencourt-Meyers and Mérieux families have increased their stake through the investment holding Téthys Invest and Mérieux Institute. Canadian pension investor PSP Investments, a long-term partner of Ceva, has also significantly increased its ownership in the group.

Other companies, part of the “Friends of Ceva” include Sofiprotéol, the investment branch of the French group Avril, Mitsui & Co., Ltd. from Japan, as well as some local investment funds and the Klocke Gruppe, are still involved in the Ceva’s adventure.

Leading the group of long-standing minority investors is the Singapore-based global investment firm Temasek, joined by French investors EMZ Partners and Sagard, Asia-based HOPU Investments, and U.S.-based Continental Grain Company.

The trust and support of these partners is essential for Ceva to achieve its financial goals and ensure the long-term independent future of the company.‎

Members of the Executive Committee